Reaction
Infusion Site Cellulitis reporting signals
As of the last recalculation, Infusion Site Cellulitis appears in 499 FAERS reports alongside 16 co-occurring drug terms. The strongest observed disproportionality signal is TREPROSTINIL (PRR 147.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Treprostinil | 236 | 147.9 | 148.2 |
| Ketoprofen | 23 | 76.6 | 76.7 |
| Amitriptyline Hydrochloride | 18 | 44.4 | 44.4 |
| Macitentan | 54 | 36.4 | 36.4 |
| Sildenafil Powder, | 28 | 34.7 | 34.7 |
| Riociguat | 25 | 33.6 | 33.6 |
| Tadalafil | 69 | 33.2 | 33.2 |
| Sildenafil | 41 | 32.1 | 32.1 |
| 0Xygen | 35 | 31.8 | 31.8 |
| Oxygen | 35 | 31.8 | 31.8 |
| Ambrisentan | 80 | 31.6 | 31.7 |
| Sildenafil Citrate | 74 | 28.3 | 28.3 |
| Rotigotine | 8 | 23.4 | 23.4 |
| Bosentan | 24 | 20.8 | 20.8 |
| Tafamidis | 3 | 10.7 | 10.7 |
| Droxidopa | 3 | 5.8 | 5.8 |